The impact of an hematocrit of 20% during normothermic cardiopulmonary bypass for elective low risk coronary artery bypass...
The impact of an hematocrit of 20% during normothermic cardiopulmonary bypass for elective low risk coronary artery bypass ... The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery ... Tyden H: Influence of body temperature during cardiopulmonary bypass on the haemodynamics early after aorto-coronary bypass ... Temperature during cardiopulmonary bypass for coronary artery operations does not influence postoperative cognitive function: a ...https://ccforum.biomedcentral.com/articles/10.1186/cc4891
Impact of Intraoperative Hypotension During Cardiopulmonary Bypass on Acute Kidney Injury After Coronary Artery Bypass Grafting
... after coronary artery bypass grafting can be attributed to intraoperative hypotension during cardiopulmonary bypass (IOH-CPB). ... Participants: Patients undergoing on-pump coronary artery bypass grafting from June 2011 to January 2014. Interventions: ... ... Author keywords: Acute kidney injury, Coronary artery bypass grafting, Hypotension, Outcome, Cardiology and Cardiovascular ...https://dspace.library.uu.nl/handle/1874/356363
Intraoperative cardiac troponin T release and lactate metabolism during coronary artery surgery: comparison of beating heart...
1996) Coronary artery bypass grafting without cardiopulmonary bypass and without interruption of native coronary flow using a ... Coronary artery surgery with cardiopulmonary bypass. Median sternotomy was performed. After harvesting the bypass graft ... Coronary artery surgery without cardiopulmonary bypass. General anaesthesia was induced by alfentanyl and maintained with ... In the case of coronary artery surgery with cardiopulmonary bypass, blood samples were obtained at the same times after cross ...http://heart.bmj.com/content/81/5/495
Effects of sevoflurane on cardiopulmonary function in patients undergoing coronary artery bypass. - Semantic Scholar
... sevoflurane immediately after the beginning of cardiopulmonary bypass (CPB) until the end of the treatment. The cardiopulmonary ... 60 cases of patients with coronary heart disease (CHD) were selected and randomly divided into the sevoflurane group (group S) ... sevoflurane may contribute to stabilizing the cardiopulmonary function and preventing from myocardial injury. ... The objective of the current study was to investigate effects of sevoflurane on cardiopulmonary function in patients undergoing ...https://www.semanticscholar.org/paper/Effects-of-sevoflurane-on-cardiopulmonary-function-Zhang-Wang/27a6fa748ff30fc69ec663055cccffdfd6e95e7a
Effect of Preliminary Administration of Cyclosporine (Sandimmun ®) on Different Markers of Cardiac Ischaemia Induced by...
Coronary Artery Bypass Surgery Cardiopulmonary Bypass Drug: Sandimmum Drug: Placebo Phase 2 ... Coronary artery bypass graft surgery (CABG). Cardiopulmonary Bypass (CPB). Cyclosporine. ischaemia reperfusion. ... MedlinePlus related topics: Coronary Artery Bypass Surgery Coronary Artery Disease Drug Information available for: Cyclosporine ... Markers of Cardiac Ischemia Led by the Aortic Cross-clamp During Coronary Artery Bypass Surgery With Cardiopulmonary Bypass.. ...https://clinicaltrials.gov/ct2/show/NCT01002859?term=ciclosporin&recr=Open&rank=23
Potential Effects of Omega 3 Supplementation on Cardiomyocytes Membranes for Patients With Coronary Atherosclerosis? - Full...
Elective cardiac surgery with sternotomy and cardiopulmonary bypass for coronary artery bypass graft. ... Coronary Artery Disease. Myocardial Ischemia. Arteriosclerosis. Arterial Occlusive Diseases. Vascular Diseases. Cardiovascular ... In a context of cardiac surgery with cardiopulmonary bypass and without deleterious side effects of preoperative enrichment in ... Preoperative omega-3 supplementation for patients undergoing cardiac surgery with cardiopulmonary bypass is correlated with a ...https://clinicaltrials.gov/ct2/show/NCT01699230
Predictors of Atrial Fibrillation After Conventional and Beating Heart Coronary Surgery | Circulation
Coronary artery bypass grafting without cardiopulmonary bypass. Ann Thorac Surg. 1996;61:63-66. ... Right coronary artery stenosis: an independent predictor of atrial fibrillation after coronary artery bypass surgery. J Am Coll ... An inexpensive method of heart stabilisation during coronary artery operation without cardiopulmonary bypass. Ann Thorac Surg. ... of frequencies of atrial fibrillation after coronary artery bypass grafting with and without the use of cardiopulmonary bypass ...http://circ.ahajournals.org/content/102/13/1530
Choice of initial medical therapy vs. prompt coronary revascularization in patients with type 2 diabetes and stable ischemic...
... in patients with type 2 diabetes and stable coronary artery disease (CAD) prevents major adverse card ... To determine whether a strategy of prompt coronary revascularization as compared with an initial strategy of intensive optimal ... 16860605 - Levosimendan for weaning from cardiopulmonary bypass after coronary artery bypass graft.... 12375185 - A prospective ... RECENT FINDINGS: Randomized controlled clinical trials comparing a strategy of prompt coronary artery bypass grafting (CABG), ...http://www.biomedsearch.com/nih/Choice-initial-medical-therapy-vs/20885315.html
Unchanged Plasma Levels of the Soluble Urokinase Plasminogen Activator Receptor in Elective Coronary Artery Bypass Graft...
Unchanged Plasma Levels of the Soluble Urokinase Plasminogen Activator Receptor in Elective Coronary Artery Bypass Graft ... Surgery Patients and Cardiopulmonary Bypass Use. . Biblioteca virtual para leer y descargar libros, documentos, trabajos y ... Patients undergoing coronary artery bypass grafting under cardiopulmonary bypass CPB were added. Based on the baseline suPAR ... Urokinase Plasminogen Activator Receptor in Elective Coronary Artery Bypass Graft Surgery Patients and Cardiopulmonary Bypass ...http://libros.duhnnae.com/2017/jun8/149838440289-Unchanged-Plasma-Levels-of-the-Soluble-Urokinase-Plasminogen-Activator-Receptor-in-Elective-Coronary-Artery-Bypass-Graft-Surgery-Patients-and-Cardiopu.php
Cardiopulmonary Bypass-Induced Lymphocytopenia and the Potential Effects of Protease Inhibitor - Full Text View -...
Any patient undergoing elective (non-emergency) cardiopulmonary bypass for coronary artery bypass grafting, cardiac valve ... Cardiopulmonary Bypass-Induced Lymphocytopenia and the Potential Effects of Protease Inhibitor. The safety and scientific ... Cardiopulmonary Bypass-Induced Lymphocytopenia and the Potential Effects of Protease Inhibitor in the Perioperative Period. ... In previous studies, 90% of patients who underwent elective cardiopulmonary bypass procedure manifested CD4 counts of less than ...https://www.clinicaltrials.gov/ct2/show/NCT00385450
Circuitul perfuziilor minime şi managementul fluidelor (volum) | Chirurgie cardiotoracică şi vasculară
Coronary artery bypass grafting with a minimized cardiopulmonary bypass circuit: a prospective, randomized trial. Sakwa MP, ... Influence of intraoperative fluid volume on cardiopulmonary bypass hematocrit and blood transfusions in coronary artery bypass ... Beneficial effects of using a minimal extracorporeal circulation system during coronary artery bypass grafting. Liu Y, Tao L, ... Minimized extracorporeal circulation system in coronary artery bypass surgery: a 10-year single-center experience with 2243 ...https://www.jw.org/ro/biblioteca-medicala/medicina-chirurgie-fara-sange/cardioMinPerfusCircFluidVolMng/
Clinical and angiographic characteristics of acute myocardial infarction caused by vasospastic angina without organic coronary...
... coronary spastic angina was diagnosed in 292 patients by performing spasm provocation tests. Among the ... Next Document: Early and mid-term impacts of cardiopulmonary bypass on coronary artery bypass grafting in patients .... ... Coronary Angiography. Coronary Artery Disease. Coronary Vasospasm / complications, diagnosis*, physiopathology. Female. Heart ... 1485385 - Congenital coronary arteriovenous fistula in a ten-year-old boy with angina pectoris.. 21053005 - Impact of therapy ...http://www.biomedsearch.com/nih/Clinical-angiographic-characteristics-acute-myocardial/17721015.html
Systematic organ protection in coronary artery surgery with or without cardiopulmonary bypass. J Card Surg 17: 529-535, 2002. ... during cardiopulmonary bypass (CPB), and also during lung transplantation. Lung injury from I/R, termed primary graft ... Therapeutic potential of potassium channel activators in coronary heart disease. Eur Heart J 15, Suppl C: 82-88, 1994. ... Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet ...http://ajplung.physiology.org/content/307/9/L668
Frontiers | Intracoronary Levosimendan during Ischemia Prevents Myocardial Apoptosis | Physiology
Pigs (n=24) were subjected to 40 minutes of global, cardioplegic ischemia under cardiopulmonary bypass and 240 minutes of ... Pigs (n=24) were subjected to 40 minutes of global, cardioplegic ischemia under cardiopulmonary bypass and 240 minutes of ... Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with ... that peri-operative levosimendan infusion facilitates weaning from cardiopulmonary bypass at coronary bypass surgery in ...https://www.frontiersin.org/articles/10.3389/fphys.2012.00017/full
Patent US8257428 - System for improving cardiac function - Google Patents
Methods and devices for minimally invasive coronary artery revascularization on a beating heart without cardiopulmonary bypass ... Ventricular remodeling in coronary artery disease. Current Opinion in Cardiology. 1997; 12:533-537. ...http://www.google.ca/patents/US8257428
Patent US20070161846 - Cardiac device and methods of use thereof - Google Patents
Methods and devices for minimally invasive coronary artery revascularization on a beating heart without cardiopulmonary bypass ...http://www.google.ca/patents/US20070161846
Patent US6416469 - Suture organizing and retaining device and base member for surgical retractor - Google Patents
... device that is attachable to surgical retractors or is usable separately in connection with minimally invasive coronary artery ... bypass grafting surgical procedures and heart valve procedures, and more specifically to a suture organizing device having a ... Methods and devices for minimally invasive coronary artery revascularization on a beating heart without cardiopulmonary bypass ... "a heart bypass" operation. The surgical correction of occluded or stenosed coronary arteries by means of bypass grafting are ...http://www.google.co.uk/patents/US6416469
Patent US5967972 - Minimally invasive surgical retractor and method of operation - Google Patents
... coronary bypass surgery, heart valve repairs, mitral valve replacement, partial sternotomies, and other types of surgery ... A retractor for use in various types of surgical procedures such as harvesting mammary arteries, ... Methods and devices for minimally invasive coronary artery revascularization on a beating heart without cardiopulmonary bypass ... A retractor for use in various types of surgical procedures such as harvesting mammary arteries, coronary bypass surgery, heart ...http://www.google.com/patents/US5967972?dq=7125605
Patent US20040138531 - Methods and apparatus for accessing and stabilizing an area of the heart - Google Patents
Methods and devices for minimally invasive coronary artery revascularization on a beating heart without cardiopulmonary bypass ... placement of the arterial bypass graphs, in situ bypass, i.e., coronary artery-venous fistulae, placement of drug delivery ... placement of the arterial bypass graphs, in situ bypass, i.e., coronary artery-venous fistulae, placement of drug delivery ... Method for coronary artery bypass. US6394948 *. Jan 28, 2000. May 28, 2002. Medtronic, Inc.. Method and apparatus for ...http://www.google.com/patents/US20040138531?dq=6,757,682
A3 adenosine receptors and mitogen-activated protein kinases in lung injury following in vivo reperfusion | Springer for...
... compared with nonpulsatile perfusion using a centrifugal pump for cardiopulmonary bypass during coronary artery bypass grafting ... and cardiopulmonary bypass . Novel therapeutic interventions for attenuation of IR lung injury remain a focus of intense ... in pig lung following cardiopulmonary bypass, expression of p38 and ERK1/2 has been demonstrated . Our results are in ... Activation of pulmonary mitogen-activated protein kinases during cardiopulmonary bypass. J Surg Res 2003, 115: 56-62. 10.1016/ ...https://rd.springer.com/article/10.1186/cc4893
Patente US20030163191 - Method for improving cardiac function - Google Patentes
Methods and devices for minimally invasive coronary artery revascularization on a beating heart without cardiopulmonary bypass ...http://www.google.es/patents/US20030163191
Indications for Coronary Artery Bypass Grafting (CABG)
Cardiopulmonary Bypass. Cardiopulmonary bypass is a technique which allows performing open heart surgical procedures in a ... Coronary Artery Bypass Graft (CABG) - Triple Bypass Surgery. Triple bypass surgery, an open heart surgery involves grafting ... Drugs for Coronary Artery Bypass Grafting Abciximab. This medication prevent blood clotting by interfering with clumping of ... Indications for Coronary Artery Bypass Grafting (CABG) depend on various factors, mainly on the individual's symptoms and ...http://www.medindia.net/patients/patientinfo/Coronary-Artery-Bypass-Grafting-indications.htm
Circulatory, Vascular and Cardiac sub-cluster 41
A patent ductus arteriosus complicating cardiopulmonary bypass for combined coronary artery bypass ... ... or the radial artery (RA) have been proposed to improve long term outcomes in coronary artery bypass grafting (CABG). RA is ... combining the benefits of both percutaneous coronary intervention and coronary artery bypass graft surgery (CABG) while ... When performing coronary artery bypass grafting, anastomotic insufficiency needs to be detected during surgery. We developed a ...http://www.biomedsearch.com/cluster/26/Circulatory-Vascular-and-Cardiac/sub-41-p8.html
UDE: Improved Therapy of myocardial infarction? - academics
... who have a blood pressure cuff several times briefly inflated before they undergo coronary artery surgery with cardiopulmonary ... bypass, the heart is protected from damage. This is the result of a clinical study recently reported by a group of scientists ... a blood pressure cuff several times briefly inflated before they undergo coronary artery surgery with cardiopulmonary bypass, ... In a myocardial infarction, parts of the cardiac muscle receive no blood supply because the coronary vessels are occluded. ...https://www.academics.com/science/ude_improved_therapy_of_myocardial_infarction_51660.html
Liver enzymes | definition of Liver enzymes by Medical dictionary
EFFECT OF CARDIOPULMONARY BYPASS ON LIVER FUNCTION IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTING ...https://medical-dictionary.thefreedictionary.com/Liver+enzymes
Download our free solidary book to support research on VHL disease